Literature DB >> 2302623

Reducing deaths from breast cancer in Canada.

I S Simor, R A Jong.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2302623      PMCID： PMC1451813     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study.

Authors:  J D Habbema; G J van Oortmarssen; D J van Putten; J T Lubbe; P J van der Maas
Journal:  J Natl Cancer Inst       Date:  1986-08       Impact factor: 13.506

2.  Mass screening in mammary cancer.

Authors:  P Strax; L Venet; S Shapiro
Journal:  Cancer       Date:  1969-04       Impact factor: 6.860

Review 3.  Assessment of the hypothetical risk from mammography and evaluation of the potential benefit.

Authors:  S A Feig
Journal:  Radiol Clin North Am       Date:  1983-03       Impact factor: 2.303

4.  Screening for breast cancer: the Swedish trial.

Authors:  L Tabàr; A Gad
Journal:  Radiology       Date:  1981-01       Impact factor: 11.105

5.  Survival experience in the Breast Cancer Detection Demonstration Project.

Authors:  H Seidman; S K Gelb; E Silverberg; N LaVerda; J A Lubera
Journal:  CA Cancer J Clin       Date:  1987 Sep-Oct       Impact factor: 508.702

Review 6.  Decreased breast cancer mortality through mammographic screening: results of clinical trials.

Authors:  S A Feig
Journal:  Radiology       Date:  1988-06       Impact factor: 11.105

7.  Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Authors:  L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

8.  The value of mammography screening in women under age 50 years.

Authors:  D M Eddy; V Hasselblad; W McGivney; W Hendee
Journal:  JAMA       Date:  1988-03-11       Impact factor: 56.272
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.